We are international
Donate

Day 4 ASH 12.11.12

| No Comments | No TrackBacks

blogicon_ASH2012_jacka.jpg

Today was the final morning at ASH with presentations from 7:30 am - 9 am. We heard about treatments with Bendamustine-Vel-dx (good results) as well as higher dose of Carfilzomib with longer infusion time (better response but it comes with higher toxicity). There was also an interesting study looking at infection rates for MM patients, who are 7 times more likely to get infections compare with non-MM folks and 12 times higher in the first year after diagnosis...so we need to be careful.

For patients diagnosed with kidney involvement (about 17% of us), novel therapies (Thal, Rev, Vel, Cfz, Pom...) has provided survival improvement. [BTW, many of these drugs are not so "novel" anymore. I was in a Thalidomide trial early '98.& Wonder why that name sticks around.]

After flying home, I'll be summarizing my results (typically a 6 pg write-up) and present them to our SF Bay Area MM support group.  I'm always happy to email it to others...just let me know if you want it.

Hope my blog has been informative, and I'm already looking forward to next year's ASH Dec 7-10 in New Orleans.

Stay well and informed.

Jack

Leave a comment

To subscribe to this blog, enter your email address below:


About this Entry

This page contains a single entry by Jack Aiello published on December 11, 2012 12:47 PM.

Day 3 ASH 12.10.12 was the previous entry in this blog.

Reflections about this year's ASH is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.